compound bpc 157 Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157: A Prohibited Peptide and

Great service and fast

Methods TACE Procedure in vivo All experimental procedures involving animals were approved by the Institutional Animal Ethics Committee of Guizhou Medical University and were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals

All of the injured rats that received BPC 157 exhibited consistent clinical improvement, increasingly better motor function of the tail, no autotomy, and resolved spasticity by day 15

It remains an investigational compound

Typically, users take 4-6 mg weekly, divided into smaller doses over 2 to 3 injections